![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1558520 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of UBL4A mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1558520 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBL4A mRNA | CTD | PMID:22206623 | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of UBL4A mRNA | CTD | PMID:22574217 | 1H-pyrazole | increases expression | ISO | RGD:1558520 | 6480464 | pyrazole results in increased expression of UBL4A mRNA | CTD | PMID:17945193 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1558520 | 6480464 | Tetrachlorodibenzodioxin affects the expression of UBL4A mRNA | CTD | PMID:21570461, PMID:24680724 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1558520 | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of UBL4A mRNA | CTD | PMID:25975270 | 2,6-dinitrotoluene | affects expression | ISO | RGD:1563983 | 6480464 | 2, 6-dinitrotoluene affects the expression of UBL4A mRNA | CTD | PMID:21346803 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1558520 | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of UBL4A mRNA | CTD | PMID:20188158 | 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1558520 | 6480464 | 4, 4'-diaminodiphenylmethane results in increased expression of UBL4A mRNA | CTD | PMID:18648102 | aflatoxin B1 | increases expression | ISO | RGD:1558520 | 6480464 | Aflatoxin B1 results in increased expression of UBL4A mRNA | CTD | PMID:19770486 | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of UBL4A polyA tail | CTD | PMID:30157460 | aflatoxin B2 | increases methylation | EXP | | 6480464 | aflatoxin B2 results in increased methylation of UBL4A 3' UTR | CTD | PMID:30157460 | Aroclor 1254 | increases expression | ISO | RGD:1558520 | 6480464 | Chlorodiphenyl 54% Chlorine results in increased expression of UBL4A mRNA | CTD | PMID:23650126 | bathocuproine disulfonic acid | multiple interactions | EXP | | 6480464 | [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of UBL4A mRNA | CTD | PMID:15477007 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzoapyrene results in increased methylation of UBL4A promoter | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzoapyrene affects the methylation of UBL4A 3' UTR | CTD | PMID:30157460 | butan-1-ol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of UBL4A mRNA | CTD | PMID:29432896 | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of UBL4A mRNA | CTD | PMID:26079696 | cadmium dichloride | affects methylation | ISO | RGD:1563983 | 6480464 | Cadmium Chloride affects the methylation of UBL4A promoter | CTD | PMID:22457795 | carbon nanotube | increases expression | ISO | RGD:1558520 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | diazinon | increases methylation | EXP | | 6480464 | Diazinon results in increased methylation of UBL4A gene | CTD | PMID:22964155 | dibutyl phthalate | decreases expression | ISO | RGD:1563983 | 6480464 | Dibutyl Phthalate results in decreased expression of UBL4A mRNA | CTD | PMID:21266533 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of UBL4A mRNA | CTD | PMID:29803840 | ethanol | affects splicing | ISO | RGD:1558520 | 6480464 | Ethanol affects the splicing of UBL4A mRNA | CTD | PMID:30319688 | finasteride | increases expression | ISO | RGD:1563983 | 6480464 | Finasteride results in increased expression of UBL4A mRNA | CTD | PMID:24136188 | flutamide | increases expression | ISO | RGD:1563983 | 6480464 | Flutamide results in increased expression of UBL4A mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | RGD:1558520 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBL4A mRNA | CTD | PMID:22206623 | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of UBL4A mRNA | CTD | PMID:28988120 | naphthalene | increases expression | ISO | RGD:1558520 | 6480464 | naphthalene results in increased expression of UBL4A mRNA | CTD | PMID:18978301 | poly(I:C) | multiple interactions | ISO | RGD:1563983 | 6480464 | [Poly I-C co-treated with HU 211] results in decreased expression of UBL4A mRNA | CTD | PMID:26923065 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromateVI results in decreased expression of UBL4A mRNA | CTD | PMID:22714537 | potassium dichromate | increases expression | EXP | | 6480464 | Potassium Dichromate results in increased expression of UBL4A protein | CTD | PMID:23718831 | progesterone | decreases expression | EXP | | 6480464 | Progesterone results in decreased expression of UBL4A mRNA | CTD | PMID:18037150 | pyrrolidine dithiocarbamate | multiple interactions | EXP | | 6480464 | [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of UBL4A mRNA | CTD | PMID:15477007 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of UBL4A mRNA | CTD | PMID:21457566 | Soman | decreases expression | ISO | RGD:1563983 | 6480464 | Soman results in decreased expression of UBL4A mRNA | CTD | PMID:19281266 | tetrachloromethane | increases expression | ISO | RGD:1558520 | 6480464 | Carbon Tetrachloride results in increased expression of UBL4A mRNA | CTD | PMID:31919559 | thapsigargin | decreases expression | ISO | RGD:1558520 | 6480464 | Thapsigargin results in decreased expression of UBL4A protein | CTD | PMID:24648495 | titanium dioxide | increases expression | ISO | RGD:1558520 | 6480464 | titanium dioxide results in increased expression of UBL4A mRNA | CTD | PMID:27760801 | topotecan | increases expression | ISO | RGD:1563983 | 6480464 | Topotecan results in increased expression of UBL4A mRNA | CTD | PMID:25729387 | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of UBL4A mRNA | CTD | PMID:28542535 | triptonide | affects expression | ISO | RGD:1558520 | 6480464 | triptonide affects the expression of UBL4A mRNA | CTD | PMID:33045310 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of UBL4A gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | RGD:1558520 | 6480464 | Valproic Acid results in decreased expression of UBL4A mRNA | CTD | PMID:21427059 | vitamin E | increases expression | EXP | | 6480464 | Vitamin E results in increased expression of UBL4A mRNA | CTD | PMID:19244175 | |